Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (PC) progression. However, androgen-refractory PC cells inevitably emerge from the androgen-responsive tumor, leading to incurable disease. Recent studies have shown AD induces cellular senescence, a phenomeno...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8c108d649c24e299fff0ac2f2a92555 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e8c108d649c24e299fff0ac2f2a92555 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e8c108d649c24e299fff0ac2f2a925552021-11-18T07:39:21ZAndrogen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.1932-620310.1371/journal.pone.0068003https://doaj.org/article/e8c108d649c24e299fff0ac2f2a925552013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23840802/?tool=EBIhttps://doaj.org/toc/1932-6203Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (PC) progression. However, androgen-refractory PC cells inevitably emerge from the androgen-responsive tumor, leading to incurable disease. Recent studies have shown AD induces cellular senescence, a phenomenon that is cell-autonomously tumor-suppressive but which confers tumor-promoting adaptations that can facilitate the advent of senescence-resistant malignant cell populations. Because androgen-refractory PC cells emerge clonally from the originally androgen-responsive tumor, we sought to investigate whether AD-induced senescence (ADIS) affects acquisition of androgen-refractory behavior in androgen-responsive LNCaP and LAPC4 prostate cancer cells. We find that repeated exposure of these androgen-responsive cells to senescence-inducing stimuli via cyclic AD leads to the rapid emergence of ADIS-resistant, androgen-refractory cells from the bulk senescent cell population. Our results show that the ADIS phenotype is associated with tumor-promoting traits, notably chemoresistance and enhanced pro-survival mechanisms such as inhibition of p53-mediated cell death, which encourage persistence of the senescent cells. We further find that pharmacologic enforcement of p53/Bax activation via Nutlin-3 prior to establishment of ADIS is required to overcome the associated pro-survival response and preferentially trigger pervasive cell death instead of senescence during AD. Thus our study demonstrates that ADIS promotes outgrowth of androgen-refractory PC cells and is consequently a suboptimal tumor-suppressor response to AD.Dominick G A BurtonMaria G GiribaldiAnisleidys MunozKatherine HalvorsenAsmita PatelMerce JordaCarlos Perez-StablePriyamvada RaiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 6, p e68003 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Dominick G A Burton Maria G Giribaldi Anisleidys Munoz Katherine Halvorsen Asmita Patel Merce Jorda Carlos Perez-Stable Priyamvada Rai Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
description |
Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (PC) progression. However, androgen-refractory PC cells inevitably emerge from the androgen-responsive tumor, leading to incurable disease. Recent studies have shown AD induces cellular senescence, a phenomenon that is cell-autonomously tumor-suppressive but which confers tumor-promoting adaptations that can facilitate the advent of senescence-resistant malignant cell populations. Because androgen-refractory PC cells emerge clonally from the originally androgen-responsive tumor, we sought to investigate whether AD-induced senescence (ADIS) affects acquisition of androgen-refractory behavior in androgen-responsive LNCaP and LAPC4 prostate cancer cells. We find that repeated exposure of these androgen-responsive cells to senescence-inducing stimuli via cyclic AD leads to the rapid emergence of ADIS-resistant, androgen-refractory cells from the bulk senescent cell population. Our results show that the ADIS phenotype is associated with tumor-promoting traits, notably chemoresistance and enhanced pro-survival mechanisms such as inhibition of p53-mediated cell death, which encourage persistence of the senescent cells. We further find that pharmacologic enforcement of p53/Bax activation via Nutlin-3 prior to establishment of ADIS is required to overcome the associated pro-survival response and preferentially trigger pervasive cell death instead of senescence during AD. Thus our study demonstrates that ADIS promotes outgrowth of androgen-refractory PC cells and is consequently a suboptimal tumor-suppressor response to AD. |
format |
article |
author |
Dominick G A Burton Maria G Giribaldi Anisleidys Munoz Katherine Halvorsen Asmita Patel Merce Jorda Carlos Perez-Stable Priyamvada Rai |
author_facet |
Dominick G A Burton Maria G Giribaldi Anisleidys Munoz Katherine Halvorsen Asmita Patel Merce Jorda Carlos Perez-Stable Priyamvada Rai |
author_sort |
Dominick G A Burton |
title |
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
title_short |
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
title_full |
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
title_fullStr |
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
title_full_unstemmed |
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
title_sort |
androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/e8c108d649c24e299fff0ac2f2a92555 |
work_keys_str_mv |
AT dominickgaburton androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT mariaggiribaldi androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT anisleidysmunoz androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT katherinehalvorsen androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT asmitapatel androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT mercejorda androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT carlosperezstable androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells AT priyamvadarai androgendeprivationinducedsenescencepromotesoutgrowthofandrogenrefractoryprostatecancercells |
_version_ |
1718423196531687424 |